○岡崎 優太1,2, 吉岡 弘鎮1, 藤井 一起1, 永田 裕太郎1, 奥野 祐希子1, 上硲 敬介1, 吉田 清里1, 生駒 龍興1, 竹安 優貴1, 勝島 詩恵1, 山中 雄太1, 倉田 宝保1 (1.関西医科大学呼吸器腫瘍内科学講座, 2.洛和会音羽病院呼吸器内科)
セッション情報
一般演題(口演)
一般演題(口演)47 KRAS遺伝子変異陽性肺癌
2024年11月2日(土) 15:40 〜 16:40 第7会場 (パシフィコ横浜ノース 3階 G314+G315)
座長:村上 晴泰(静岡がんセンター呼吸器内科), 坂 英雄(松波総合病院呼吸器内科)
○Yutaka Fujiwara1, Timothy F. Burns2, Konstantin H. Dragnev3, Yonina R. Murciano-Goroff4, Dae Ho Lee5, Antoine Hollebecque6, Takafumi Koyama7, Philippe Cassier8, Antoine Italiano9, Rebecca S. Heist10, Ji-Youn Han11, Dustin Deming12, Alexander I. Spira13, Joshua K. Sabari14, Michael J. Chisamore15, Aaron Fink16, Aaron Chen16, Melinda D. Willard16, Geoffrey R. Oxnard16, Natraj Reddy Ammakkanavar17 (1.Aichi Cancer Center Hospital, Aichi, Japan, 2.Department of Medicine, Division of Hematology Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA, 3.Department of Hematology/Oncology, Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 4.Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 5.Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, 6.Gustave Roussy, Villejuif, France, 7.Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan, 8.Department of Medical Oncology, Centre Léon Bérard, Lyon, France, 9.Early Phase Trials Unit, Institut Bergonié, Bordeaux, France, 10.Massachusetts General Hospital, Boston, MA, USA, 11.Research Institute, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea, 12.Carbone Cancer Center, University of Wisconsin, Madison, WI, USA, 13.Virginia Cancer Specialists, Fairfax, VA, USA, 14.NYU Langone Health – Perlmutter & Long Island, New York, NY, USA, 15.Merck & Co., Inc. Rahway, NJ, USA, 16.Loxo@Lilly, Stamford, CT, USA, 17.Community Health Network, Indianapolis, IN, USA)
○Yutaka Fujiwara1, Rebecca S. Heist2, Takafumi Koyama3, Yonina R. Murciano-Goroff4, Antoine Hollebecque5, Philippe Cassier6, Ji-Youn Han7, Diego Tosi8, Adrian Sacher9, Timothy F. Burns10, Alexander I. Spira11, Carlos-Alberto Gomez-Roca12, Toshio Shimizu13, Natraj Reddy Ammakkanavar14, Joshua K. Sabari15, Misako Nagasaka16, Aaron Fink17, Aaron Chen17, Melinda D. Willard17, Geoffrey R. Oxnard17, Yasutoshi Kuboki18 (1.Aichi Cancer Center Hospital, Aichi, Japan, 2.Massachusetts General Hospital, Boston, MA, USA, 3.Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan, 4.Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 5.Gustave Roussy, Villejuif, France, 6.Department of Medical Oncology, Centre Léon Bérard, Lyon, France, 7.Research Institute, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea, 8.Institut régional du Cancer de Montpellier(ICM), Montpellier, France, 9.Department of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Canada, 10.Department of Medicine, Division of Hematology Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA, 11.Virginia Cancer Specialists, Fairfax, VA, USA, 12.Institut Universitaire du Cancer de Toulouse(IUCT)-Oncopole, Toulose, France, 13.Wakayama Medical University Hospital, Wakayama, Japan, 14.Community Health Network, Indianapolis, IN, USA, 15.NYU Langone Health - Perlmutter & Long Island, New York, NY, USA, 16.University of California Irvine School of Medicine, Orange, CA, USA, 17.Loxo@Lilly, Stamford, CT, USA, 18.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan)
○Makoto Nishio1, Marcelo V. Negrao2, Kathryn C. Arbour3, Timothy F. Burns4, Federico Cappuzzo5, Anne-Marie C. Dingemans6, Nicolas Girard7, Bjorn Henning Gronberg8, Maximilian Hochmair9, Ticiana Leal10, Colin R. Lindsay11, Shun Lu12, Luis G. Paz-Ares13, Martin Reck14, Joshua K. Sabari15, Alexander I. Spira16, William N. William17, Aaron Chen18, Alyson Merced18, Carla M. Visseren-Grul19, Solange Peters20 (1.Department of Thoracic Medical Oncology Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, 2.Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 3.Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 4.Department of Medicine, Division of Hematology Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA, 5.Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy, 6.Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands, 7.Institut du Thorax Curie Montsouris, Institut Curie, Paris, France and UVSQ, Paris Saclay, Versailles, France, 8.Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, 9.Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria, 10.Winship Cancer Institute at Emory University, Atlanta, GA, USA, 11.Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK, 12.Department of Medical Oncology, Shanghai Chest Hospital, Shanghai, China, 13.Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain, 14.Department of Thoracic Oncology, LungenClinic Grosshansdorf, Airway Research Center North(ARCN), Grosshansdorf, Germany, 15.NYU Langone Health - Perlmutter & Long Island, New York, NY, USA, 16.Virginia Cancer Specialists, Fairfax, VA, USA, 17.Grupo Oncoclínicas, São Paulo, Brazil, 18.Loxo@Lilly, Stamford, CT, USA, 19.Eli Lilly and Company, Utrecht, Netherlands, 20.Oncology Department, Lausanne University and CHUV, Lausanne, Switzerland)
講演取消
○吉澤 孝浩, 飯塚 昇, 臼井 優介, 清水 宏繁, 関谷 宗之, 三好 嗣臣, 卜部 尚久, 一色 琢磨, 坂本 晋, 岸 一馬 (東邦大学医学部内科学講座呼吸器内科学分野(大森))